Akadeum Life Sciences Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $4.05M
Latest Deal Amount
  • Investors
  • 18

Akadeum Life Sciences General Information

Description

Developer of bio-separation products designed to facilitate the removal of target cells from biological samples. The company's products are based on buoyancy-activated cell sorting (BACS) that uses microscopic micro-bubbles to capture target cells and quickly float them to the surface of a liquid sample for removal, enabling medical practitioners to use those cells for performing downstream testing and analysis with increased efficiency.

Contact Information

Website
www.akadeum.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 674 South Wagner Road
  • Ann Arbor, MI 48103
  • United States
+1 (734) 000-0000

Akadeum Life Sciences Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Akadeum Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 28-Apr-2020 $4.05M 00.000 0000 Completed Generating Revenue
6. Early Stage VC 01-Feb-2019 000 00.000 Completed Generating Revenue
5. Seed Round 28-Sep-2017 00.000 00.000 00.000 Completed Generating Revenue
4. Seed Round 31-Jul-2015 000 00.000 00.00 Completed Generating Revenue
3. Seed Round 21-Oct-2014 00000 00000 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Grant 01-Mar-2014 $50K Completed Generating Revenue
To view Akadeum Life Sciences’s complete valuation and funding history, request access »

Akadeum Life Sciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A-1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00
Seed Prime 5,393,132 $0.001000 $0.03 $0.33 $0.33 1x $0.33 13.21%
Seed 3,627,200 $0.001000 $0.02 $0.29 $0.29 1x $0.29 8.89%
To view Akadeum Life Sciences’s complete cap table history, request access »

Akadeum Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of bio-separation products designed to facilitate the removal of target cells from biological samples. The com
Diagnostic Equipment
Ann Arbor, MI
4 As of 2015
00.000
000 0000-00-00
00000000000 00.000

00000000

e et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000000000 000000000
Fremont, CA
000 As of 0000
000.00
000000&0 000.00

0-00000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
0000000000 000000000
Uppsala, Sweden
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Akadeum Life Sciences Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DiscoverX Formerly VC-backed Fremont, CA 000 000.00 000000&0 000.00
0-00000 Formerly VC-backed Uppsala, Sweden 000 00000 00000000 00000
000000000 00000000 Corporation Carlsbad, CA 000000000 -
00000000 Corporation Alameda, CA 00 000000000 -
000000000 Venture Capital-Backed Seraing, Belgium 000 00.000 0000000000 0 00.000
You’re viewing 5 of 21 competitors. Get the full list »

Akadeum Life Sciences Executive Team (9)

Name Title Board Seat Contact Info
Brandon McNaughton Ph.D Co-Founder, Chief Executive Officer & Board Member
Eric Halverson Chief Financial Officer
Brock Siegel Ph.D Board Member & Contract- Chief Operating Officer
George Dunbar Jr. Executive Chairman & Board Member
You’re viewing 4 of 9 executive team members. Get the full list »

Akadeum Life Sciences Board Members (8)

Name Representing Role Since
Brandon McNaughton Ph.D Akadeum Life Sciences Co-Founder, Chief Executive Officer & Board Member 000 0000
Brock Siegel Ph.D Akadeum Life Sciences Board Member & Contract- Chief Operating Officer 000 0000
Douglas Neal eLab Ventures Board Member 000 0000
George Dunbar Jr. Akadeum Life Sciences Executive Chairman & Board Member 000 0000
Michael Linderman Akadeum Life Sciences Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Akadeum Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akadeum Life Sciences Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agilent Technologies Corporation Minority 000 0000 000000 0
Berkeley Catalyst Fund Venture Capital Minority 000 0000 000000 0
Cantilever Investors Venture Capital Minority 000 0000 000000 0
Michigan Angel Fund Angel Group Minority 000 0000 000000 0
Michigan Capital Network Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial